Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01316549 · ClinicalTrials.gov registry record
Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 67
- Enrollment target
NCT01316549 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 67 participants.
The verdict
NCT01316549 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
Study Summary
Fludarabine is a chemotherapy drug used extensively in bone marrow transplantation. The goal of this study is to determine what causes some children to have different drug concentrations of fludarabine in their bodies and if drug levels are related to whether or not a child experiences severe side-effects during their bone marrow transplant. The hypothesis is that clinical and genetic factors cause changes in fludarabine drug levels in pediatric bone marrow transplant patients and that high levels may cause severe side-effects.
Interventions
- DRUG Fludarabine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2011-01-01 |
| Est. Completion | 2016-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01316549
The ClinicalTrials.gov registry entry for NCT01316549 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fludarabine is the first listed.
NCT01316549 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01316549 about?
NCT01316549 is a clinical study titled "Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation". Fludarabine is a chemotherapy drug used extensively in bone marrow transplantation. The goal of this study is to determine what causes some children to have different drug concentrations of fludarabine in their bodies and if drug levels are related to whether or not a child experiences severe side-e...
What is the current status of trial NCT01316549?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2011-01-01. Estimated completion is 2016-04-30.
What interventions are being tested in trial NCT01316549?
The interventions under investigation include: Fludarabine (DRUG).
Who is sponsoring clinical trial NCT01316549?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.